Klaus Veitinger

Klaus Veitinger is the founder of Promentis Pharmaceuticals. Promentis Pharmaceuticals has raised $31M in total funding. Latest round: Series C.

About Klaus Veitinger

Klaus Veitinger is the CEO and Chairman of the Board at Promentis Pharmaceuticals, as well as an OrbiMed Venture Partner. He leads the team focused on developing first-in-class therapies for neuropsychiatric disorders, including their lead compound SXC-2023.

Klaus Veitinger at a glance

More founders in Milwaukee, United States (44)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library